Below are the most recent publications written about "Community-Acquired Infections" by people in Profiles.
-
Deshpande A, Klompas M, Guo N, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2023 07 26; 77(2):174-185.
-
Steinig E, Aglua I, Duchene S, Meehan MT, Yoannes M, Firth C, Jaworski J, Drekore J, Urakoko B, Poka H, Wurr C, Ebos E, Nangen D, M?ller E, Mulvey P, Jackson C, Blomfeldt A, Aamot HV, Laman M, Manning L, Earls M, Coleman DC, Greenhill A, Ford R, Stegger M, Syed MA, Jamil B, Monecke S, Ehricht R, Smith S, Pomat W, Horwood P, Tong SYC, McBryde E. Phylodynamic signatures in the emergence of community-associated MRSA. Proc Natl Acad Sci U S A. 2022 Nov 08; 119(45):e2204993119.
-
Rothberg MB, Haessler S, Deshpande A, Yu PC, Lindenauer PK, Zilberberg MD, Higgins TL, Imrey PB. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 Jul; 44(7):1143-1150.
-
Rothberg MB, Imrey PB, Guo N, Deshpande A, Higgins TL, Lindenauer PK. A risk model to identify Legionella among patients admitted with community-acquired pneumonia: A retrospective cohort study. J Hosp Med. 2022 08; 17(8):624-632.
-
Patel P, Deshpande A, Yu PC, Imrey PB, Lindenauer PK, Zilberberg MD, Haessler S, Rothberg MB. Association of fluoroquinolones or cephalosporin plus macrolide with Clostridioides difficile infection (CDI) after treatment for community-acquired pneumonia. Infect Control Hosp Epidemiol. 2023 01; 44(1):47-54.
-
Qu MD, Kausar H, Smith S, Lazar PG, Kroll-Desrosiers AR, Hollins C, Barton BA, Ward DV, Ellison RT. Epidemiological and clinical features of Panton-Valentine Leukocidin positive Staphylococcus aureus bacteremia: A case-control study. PLoS One. 2022; 17(3):e0265476.
-
Haessler S, Guo N, Deshpande A, Zilberberg MD, Lagu T, Lindenauer PK, Imrey PB, Rothberg MB. Etiology, Treatments, and Outcomes of Patients With Severe Community-Acquired Pneumonia in a Large U.S. Sample. Crit Care Med. 2022 07 01; 50(7):1063-1071.
-
Deshpande A, Klompas M, Yu PC, Imrey PB, Pallotta AM, Higgins T, Haessler S, Zilberberg MD, Lindenauer PK, Rothberg MB. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia. Chest. 2022 09; 162(3):543-555.
-
Ruhnke GW, Lindenauer PK, Lyttle CS, Meltzer DO. The Impact of Principal Diagnosis on Readmission Risk among Patients Hospitalized for Community-Acquired Pneumonia. Am J Med Qual. 2022 Jul-Aug 01; 37(4):307-313.
-
Bartley PS, Deshpande A, Yu PC, Klompas M, Haessler SD, Imrey PB, Zilberberg MD, Rothberg MB. Bacterial coinfection in influenza pneumonia: Rates, pathogens, and outcomes. Infect Control Hosp Epidemiol. 2022 02; 43(2):212-217.